On Thursday, August 27, 1:00 p.m.-2:30 p.m. ET, the U.S. Food and Drug Administration (FDA) will host a webinar for developers and manufacturers of neurological and physical medicine devices on the De Novo pathway, a potential pathway to market new medical devices for which there is no legally marketed predicate device.
This webinar will provide:
- An introduction to the FDA’s role in facilitating innovation in neurological and physical medicine device technology.
- An overview of the De Novo classification process.
- Information on working with the FDA and the pre-submission process.
No hay comentarios:
Publicar un comentario